RNA‐binding protein NONO promotes breast cancer proliferation by post‐transcriptional regulation of SKP2 and E2F8
Iino, Kaori, Mitobe, Yuichi, Ikeda, Kazuhiro, Takayama, Ken‐ichi, Suzuki, Takashi, Kawabata, Hidetaka, Suzuki, Yutaka, Horie‐Inoue, Kuniko, Inoue, Satoshi
Published in Cancer science (01.01.2020)
Published in Cancer science (01.01.2020)
Get full text
Journal Article
PSF promotes ER-positive breast cancer progression via posttranscriptional regulation of ESR1 and SCFD2
Mitobe, Yuichi, Iino, Kaori, Takayama, Ken-Ichi, Ikeda, Kazuhiro, Suzuki, Takashi, Aogi, Kenjiro, Kawabata, Hidetaka, Suzuki, Yutaka, Horie-Inoue, Kuniko, Inoue, Satoshi
Published in Cancer research (Chicago, Ill.) (01.06.2020)
Published in Cancer research (Chicago, Ill.) (01.06.2020)
Get full text
Journal Article
Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B)
Ozaki, Yukinori, Tsurutani, Junji, Mukohara, Toru, Iwasa, Tsutomu, Takahashi, Masato, Tanabe, Yuko, Kawabata, Hidetaka, Masuda, Norikazu, Futamura, Manabu, Minami, Hironobu, Matsumoto, Koji, Yoshimura, Kenichi, Kitano, Shigehisa, Takano, Toshimi
Published in European journal of cancer (1990) (01.08.2022)
Published in European journal of cancer (1990) (01.08.2022)
Get full text
Journal Article
PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2
Takeiwa, Toshihiko, Ikeda, Kazuhiro, Suzuki, Takashi, Sato, Wataru, Iino, Kaori, Mitobe, Yuichi, Kawabata, Hidetaka, Horie, Kuniko, Inoue, Satoshi
Published in Scientific reports (09.06.2022)
Published in Scientific reports (09.06.2022)
Get full text
Journal Article
OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH
Ogura, Takuya, Azuma, Kotaro, Sato, Junichiro, Kinowaki, Keiichi, Takayama, Ken-Ichi, Takeiwa, Toshihiko, Kawabata, Hidetaka, Inoue, Satoshi
Published in International journal of molecular sciences (25.10.2021)
Published in International journal of molecular sciences (25.10.2021)
Get full text
Journal Article
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
Masuda, Norikazu, Bando, Hiroko, Yamanaka, Takashi, Kadoya, Takayuki, Takahashi, Masato, Nagai, Shigenori E., Ohtani, Shoichiro, Aruga, Tomoyuki, Suzuki, Eiji, Kikawa, Yuichiro, Yasojima, Hiroyuki, Kasai, Hiroi, Ishiguro, Hiroshi, Kawabata, Hidetaka, Morita, Satoshi, Haga, Hironori, Kataoka, Tatsuki R., Uozumi, Ryuji, Ohno, Shinji, Toi, Masakazu
Published in Breast cancer research and treatment (01.07.2021)
Published in Breast cancer research and treatment (01.07.2021)
Get full text
Journal Article
Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
Takahashi, Momoko, Ozaki, Yukinori, Kizawa, Rika, Masuda, Jun, Sakamaki, Kentaro, Kinowaki, Keiichi, Umezu, Taro, Kondoh, Chihiro, Tanabe, Yuko, Tamura, Nobuko, Miura, Yuji, Shigekawa, Takashi, Kawabata, Hidetaka, Baba, Noriyuki, Iguchi, Haruo, Takano, Toshimi
Published in BMC cancer (22.10.2019)
Published in BMC cancer (22.10.2019)
Get full text
Journal Article
Combined A20 and tripartite motif‐containing 44 as poor prognostic factors for breast cancer patients of the Japanese population
Sato, Junichiro, Azuma, Kotaro, Kinowaki, Keiichi, Ikeda, Kazuhiro, Ogura, Takuya, Takazawa, Yutaka, Kawabata, Hidetaka, Kitagawa, Masanobu, Inoue, Satoshi
Published in Pathology international (01.01.2021)
Published in Pathology international (01.01.2021)
Get full text
Journal Article
TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling
Kawabata, Hidetaka, Azuma, Kotaro, Ikeda, Kazuhiro, Sugitani, Ikuko, Kinowaki, Keiichi, Fujii, Takeshi, Osaki, Akihiko, Saeki, Toshiaki, Horie-Inoue, Kuniko, Inoue, Satoshi
Published in International journal of molecular sciences (08.09.2017)
Published in International journal of molecular sciences (08.09.2017)
Get full text
Journal Article
TRIM39 is a poor prognostic factor for patients with estrogen receptor‐positive breast cancer and promotes cell cycle progression
Ogura, Takuya, Azuma, Kotaro, Takeiwa, Toshihiko, Sato, Junichiro, Kinowaki, Keiichi, Ikeda, Kazuhiro, Kawabata, Hidetaka, Inoue, Satoshi
Published in Pathology international (01.02.2022)
Published in Pathology international (01.02.2022)
Get full text
Journal Article
Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
Tanabe, Yuko, Shiraishi, Seiji, Hashimoto, Kenji, Ikeda, Kazutaka, Nishizawa, Daisuke, Hasegawa, Junko, Shimomura, Akihiko, Ozaki, Yukinori, Tamura, Nobuko, Yunokawa, Mayu, Yonemori, Kan, Takano, Toshimi, Kawabata, Hidetaka, Tamura, Kenji, Fujiwara, Yasuhiro, Shimizu, Chikako
Published in BMC cancer (16.04.2020)
Published in BMC cancer (16.04.2020)
Get full text
Journal Article
Clinical prediction model based on 18F-FDG PET/CT plus contrast-enhanced MRI for axillary lymph node macrometastasis
Kawaguchi, Shun, Tamura, Nobuko, Tanaka, Kiyo, Kobayashi, Yoko, Sato, Junichiro, Kinowaki, Keiichi, Shiiba, Masato, Ishihara, Makiko, Kawabata, Hidetaka
Published in Frontiers in oncology (13.09.2022)
Published in Frontiers in oncology (13.09.2022)
Get full text
Journal Article
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
Fukada, Ippei, Ito, Yoshinori, Kondo, Naoto, Ohtani, Shoichiro, Hattori, Masaya, Tokunaga, Eriko, Matsunami, Nobuki, Mashino, Kohjiro, Kosaka, Taijiro, Tanabe, Masahiko, Yotsumoto, Daisuke, Yamanouchi, Kosho, Sawaki, Masataka, Kashiwaba, Masahiro, Kawabata, Hidetaka, Kuroi, Katsumasa, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu, Masuda, Norikazu
Published in Breast cancer research and treatment (01.12.2021)
Published in Breast cancer research and treatment (01.12.2021)
Get full text
Journal Article
Estrogen-Inducible LncRNA BNAT1 Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells
Horie, Kuniko, Takagi, Kiyoshi, Takeiwa, Toshihiko, Mitobe, Yuichi, Kawabata, Hidetaka, Suzuki, Takashi, Ikeda, Kazuhiro, Inoue, Satoshi
Published in Cells (Basel, Switzerland) (15.11.2022)
Published in Cells (Basel, Switzerland) (15.11.2022)
Get full text
Journal Article
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
Masuda, Jun, Sakai, Hitomi, Tsurutani, Junji, Tanabe, Yuko, Masuda, Norikazu, Iwasa, Tsutomu, Takahashi, Masato, Futamura, Manabu, Matsumoto, Koji, Aogi, Kenjiro, Iwata, Hiroji, Hosonaga, Mari, Mukohara, Toru, Yoshimura, Kiyoshi, Imamura, Chiyo K, Miura, Sakiko, Yamochi, Toshiko, Kawabata, Hidetaka, Yasojima, Hiroyuki, Tomioka, Nobumoto, Yoshimura, Kenichi, Takano, Toshimi
Published in Journal for immunotherapy of cancer (01.09.2023)
Published in Journal for immunotherapy of cancer (01.09.2023)
Get full text
Journal Article
Complete spontaneous regression of primary diffuse large B-cell lymphoma of the breast
Iwatani, Tsuguo, Kawabata, Hidetaka, Miura, Daishu, Ota, Yasunori, Ohashi, Kenichi
Published in Journal of clinical oncology (10.02.2011)
Published in Journal of clinical oncology (10.02.2011)
Get full text
Journal Article
Data of programmed death-ligand 1 expression and VEGF: Nivolumab, bevacizumab and paclitaxel For HER2-negative metastatic breast cancer
Ozaki, Yukinori, Tsurutani, Junji, Mukohara, Toru, Iwasa, Tsutomu, Takahashi, Masato, Tanabe, Yuko, Kawabata, Hidetaka, Masuda, Norikazu, Futamura, Manabu, Minami, Hironobu, Matsumoto, Koji, Yoshimura, Kenichi, Kitano, Shigehisa, Takano, Toshimi
Published in Data in brief (01.12.2022)
Published in Data in brief (01.12.2022)
Get full text
Journal Article
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study
Ozaki, Yukinori, Tanabe, Yuko, Tamura, Nobuko, Ogura, Takuya, Kondoh, Chihiro, Miura, Yuji, Yoshimura, Kenichi, Kawabata, Hidetaka, Takano, Toshimi
Published in Breast cancer (Tokyo, Japan) (01.05.2018)
Published in Breast cancer (Tokyo, Japan) (01.05.2018)
Get full text
Journal Article